This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Is Clorox (CLX) Up 5.4% Since Last Earnings Report?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SCI Stock Rallies 28% in Six Months: What's Next for Investors?
by Zacks Equity Research
While Service Corporation's essential services and strategic efforts offer resilience, flat revenue growth in the Cemetery unit and high costs are concerns.
KMB Faces Q4 Hurdles, Banks on Innovation & Efficiency for Growth
by Zacks Equity Research
While Kimberly-Clark faces short-term hurdles from a dynamic retail landscape and high promotional costs, its strategic initiatives set a foundation for growth.
Here's Why Clorox (CLX) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Clorox Stock Hits 52-Week High: Is it Time to Buy, Hold or Sell?
by Zacks Equity Research
CLX looks poised for growth through recent recovery, improved distribution channels, and focus on innovation and expansion amid inflation and cost headwinds.
PG's Premium P/E Valuation: Value Opportunity or Risky Proposition?
by Rajani Lohia
While Procter & Gamble's near-term outlook suggests challenges due to ongoing tensions, its strategies and execution indicate long-term growth potential.
Is Clorox (CLX) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and US Foods (USFD) have performed compared to their sector so far this year.
The Clorox Company (CLX) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Clorox (CLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
5 Defensive Stocks to Counter Volatility as Post-Election Rally Halts
by Ritujay Ghosh
Low-beta defensive stocks like AGR, ATO, DTE, CLX and INGR are a safe bet during times of market volatility.
Vital Farms Q3 Earnings Beat Estimates on Higher Sales & Gross Margin
by Zacks Equity Research
VITL Q3 results reflect robust sales momentum driven by higher volumes and favorable pricing, supported by its focus on ethical food production.
Is Mission Produce (AVO) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Mission Produce, Inc. (AVO) and Clorox (CLX) have performed compared to their sector so far this year.
Clorox Stock Gains 3.8% in a Week on Solid Q1 Results: Buy or Avoid?
by Zacks Equity Research
CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Beat the Market the Zacks Way: Bank of New York Mellon, PetMed, Ulta Beauty in Focus
by Santanu Roy
Our time-tested methodologies helped investors navigate the market well last week. Here are some of our key performance data from the past three months.
CHD Q3 Earnings Beat, Robust Consumer Demand Drives Sales Growth
by Zacks Equity Research
Church & Dwight's Q3 results reflect increased sales and earnings on strong consumer demand, resilience of its brands and successful new product launches.
CLX Q1 Earnings & Sales Beat Estimates, Raised FY25 View Drives Stock
by Zacks Equity Research
Clorox's Q1 results reflect a recovery from last year's cyberattack-related woes. Organic sales across all segments and margin expansion boost its performance.
Clorox (CLX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Clorox (CLX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Clorox (CLX) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 36.76% and 8.13%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Will Soft Ag Services & Oilseeds Performance Mar ADM's Q3 Earnings?
by Zacks Equity Research
Archer Daniels' Q3 results are expected to reflect continued weak trends in the Agricultural Services & Oilseeds segment, and soft crush margins.
AB InBev to Post Q3 Earnings: Essential Insights Ahead of the Report
by Zacks Equity Research
BUD's Q3 results are expected to reflect the benefits of premiumization efforts, its diverse brand portfolio, pricing strategies and revenue management plans.
Church & Dwight to Report Q3 Earnings: Here's What You Should Know
by Zacks Equity Research
CHD's robust brand equity, commitment to innovation and new products set it up for a decent Q3 sales result despite a challenging consumer spending landscape.
Clorox (CLX) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Clorox (CLX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
Clorox Gears Up for Q1 Earnings: Here's What You Should Know
by Zacks Equity Research
CLX's first-quarter fiscal 2025 results are likely to gain from pricing and cost-saving efforts. It aims at innovation and brand building.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Consumer Staples Names
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
EL Gears Up for Q1 Earnings Release: Here's What You Should Know
by Zacks Equity Research
EL's fiscal first-quarter results are likely to reflect difficulties in mainland China and Asia travel retail due to persistently weak consumer sentiment.
Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for NOBL